Researchers and a patient advocate weighed in on current and emerging treatment options for each stage of triple-negative breast...
Former Vice President Joe Biden returned to the stage at the American Association for Cancer Research (AACR) Annual Meeting...
Now that a plethora of clinical trials have established positive responses from immunotherapies—immune checkpoint inhibitors, in particular—in patients with...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic niraparib (Zejula) for the...
April symbolizes a progressive time for cancer researchers around the world. From April 1-5, over 20,000 cancer scientists will...
As part of a growing public affairs program, the American Association for Cancer Research is excited to once again...
A big career fair can be somewhat intimidating, so we asked some hiring experts for their advice on how...
At the 2017 Annual Meeting, the AACR is expanding its social media profile to include Snapchat and Instagram.
In addition to the robust scientific program at this year’s AACR Annual Meeting in Washington, D.C., a number of...
The U.S. Food and Drug Administration (FDA) has approved expanding the use of the immunotherapeutic pembrolizumab (Keytruda) to include...
The American Association for Cancer Research was shocked last week to learn that the Trump administration has proposed to...